报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 6.18% | -10.95% | -61.47% | 6/71 | 2.21% | ST目药 | 9.27% | 行业排名> |
2024-12-31 | 16.04% | 6.44% | 7% | 8/71 | 3.08% | ST目药 | 22.26% | 行业排名> |
2024-09-30 | 14.99% | 10.79% | 26.39% | 5/71 | 3% | 羚锐制药 | 20.44% | 行业排名> |
2024-06-30 | 11.86% | 13.49% | 70.89% | 4/71 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
2024-03-31 | 6.94% | 6.12% | -53.95% | 2/71 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
2023-12-31 | 15.07% | 9.6% | 11.38% | 10/71 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
2023-09-30 | 13.53% | 10% | 29.47% | 9/71 | 7.09% | 太极集团 | 22.08% | 行业排名> |
2023-06-30 | 10.45% | 22.37% | 59.79% | 8/71 | 4.8% | 太极集团 | 17.13% | 行业排名> |
2023-03-31 | 6.54% | 22.47% | -52.44% | 7/71 | 2.65% | 以岭药业 | 10.43% | 行业排名> |
2022-12-31 | 13.75% | 7.84% | 11.79% | 13/71 | 7.39% | *ST吉药 | 72.63% | 行业排名> |
2022-09-30 | 12.3% | 0.74% | 44.03% | 9/71 | 5.07% | 片仔癀 | 19.69% | 行业排名> |
2022-06-30 | 8.54% | -4.37% | 59.93% | 9/71 | 3.13% | 片仔癀 | 12.75% | 行业排名> |
2022-03-31 | 5.34% | 16.59% | -58.12% | 7/71 | 2.15% | 片仔癀 | 6.88% | 行业排名> |
2021-12-31 | 12.75% | 24.51% | 4.42% | 15/71 | 4.45% | 片仔癀 | 27.39% | 行业排名> |
2021-09-30 | 12.21% | 3.04% | 36.73% | 9/71 | 7.44% | 片仔癀 | 23.14% | 行业排名> |
2021-06-30 | 8.93% | 24.72% | 94.98% | 8/71 | 4.61% | 片仔癀 | 13.23% | 行业排名> |
2021-03-31 | 4.58% | 13.93% | -55.27% | 10/71 | -2.87% | *ST长药 | 7.37% | 行业排名> |
2020-12-31 | 10.24% | -0.39% | -13.59% | 26/71 | -2.08% | 沃华医药 | 22.84% | 行业排名> |
2020-09-30 | 11.85% | -29.67% | 65.5% | 9/71 | 5.56% | 沃华医药 | 19.47% | 行业排名> |
2020-06-30 | 7.16% | -17.13% | 78.11% | 11/71 | 3.25% | 沃华医药 | 12.7% | 行业排名> |
2020-03-31 | 4.02% | -60.7% | -60.89% | 9/71 | 1.91% | 济川药业 | 7.33% | 行业排名> |
2019-12-31 | 10.28% | -15.25% | -38.99% | 26/71 | 3.89% | 济川药业 | 27.43% | 行业排名> |
2019-09-30 | 16.85% | 55.16% | 95.02% | 3/71 | 7.09% | 济川药业 | 23.05% | 行业排名> |
2019-06-30 | 8.64% | 9.37% | -15.54% | 10/71 | 4.58% | 济川药业 | 15.79% | 行业排名> |
2019-03-31 | 10.23% | 142.99% | -15.66% | 1/71 | 2.86% | 华润三九 | 10.23% | 行业排名> |
2018-12-31 | 12.13% | -0.08% | 11.69% | 22/71 | 7.68% | 济川药业 | 32.79% | 行业排名> |
2018-09-30 | 10.86% | 2.36% | 37.47% | 15/71 | 7.89% | 济川药业 | 27.55% | 行业排名> |
2018-06-30 | 7.9% | 1.54% | 87.65% | 10/71 | 4.92% | 济川药业 | 17.62% | 行业排名> |
2018-03-31 | 4.21% | -1.17% | -65.32% | 12/71 | 2.71% | 济川药业 | 10.07% | 行业排名> |
2017-12-31 | 12.14% | -8.03% | 14.42% | 22/71 | 9.76% | ST葫芦娃 | 46.01% | 行业排名> |
2017-09-30 | 10.61% | -2.66% | 36.38% | 20/71 | 8.29% | 济川药业 | 24.2% | 行业排名> |
2017-06-30 | 7.78% | 0.65% | 82.63% | 16/71 | 5.16% | *ST大药 | 15.31% | 行业排名> |
2017-03-31 | 4.26% | 5.45% | -67.73% | 11/71 | 2.6% | 济川药业 | 14.64% | 行业排名> |
2016-12-31 | 13.2% | -9.65% | 21.1% | 23/71 | 9.95% | 济川药业 | 7.64% | 行业排名> |
2016-09-30 | 10.9% | -6.76% | 41.01% | 18/71 | 9.31% | 维康药业 | 38.23% | 行业排名> |
2016-06-30 | 7.73% | -11.86% | 91.34% | 17/71 | 5.02% | 太极集团 | 58.41% | 行业排名> |
2016-03-31 | 4.04% | -17.38% | -72.35% | 17/71 | 4.04% | 新光药业 | 16.54% | 行业排名> |
2015-12-31 | 14.61% | -5.13% | 24.98% | 25/71 | 11.27% | 太极集团 | 71.6% | 行业排名> |
2015-09-30 | 11.69% | -3.87% | 33.3% | 18/71 | 8.43% | 维康药业 | 48.67% | 行业排名> |
2015-06-30 | 8.77% | -7.49% | 79.35% | 14/71 | 5.48% | 济川药业 | 21.37% | 行业排名> |
2015-03-31 | 4.89% | 3.6% | -68.25% | 7/71 | 2.93% | 贵州三力 | 15.84% | 行业排名> |